Its a Management issue plain and simple. A question to clarify a statement is acceptable but to miss another promise is a lack of experience and planning. Funding could be another problem if questions are not answered correctly the first time. Its all about trust and integrity. The sky is still "blue" but shareholders can only validate the company based on PR's , PPS, filings , other facts but not "non" public information!! How many restricted shares become free trading shares this year? Hundreds of thousand shareholders ???? Imagine each holding 2000 shares..........what are the totals in GNBT/NGIO??? I dont think this Management team is capable to take it to the "big" pharma level, prove me wrong!!
Post 213 says it all !!
Lot of positive events too but unfortunately we cant live in the past !!